Dr. Udelson is an invited advisor to the FDA’s Division of Medical Imaging and Hematology Products and has been invited as an ad hoc member of the FDA’s Cardiovascular and Renal Drugs Advisory Panel and the Peripheral and Central Nervous System Advisory Panel. Dr. Udelson’s research interests involve studying the effects of new therapeutic modalities in the setting of heart failure and chronic coronary artery disease, as well as studying the development of imaging modalities to assess those effects. He has directed and/or participated in numerous clinical trials on heart failure and cardiac imaging, focusing on the role of new therapies and how they affect remodeling, physiology, function, and outcomes.

BACK TO TEAM